Golden Seeds Fund LP

Massachusetts
Firm Location:Massachusetts • New York, New York
Golden Seeds Fund LP Team
Photo of Lynn Baine, General Partner at Golden Seeds Fund LP
Lynn Baine
Golden Seeds Fund LP·General Partner
Sweet spot: $1M
Range: $250K - $2.0M
Investors in New York (NY)
Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Internet (Seed), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Infrastructure (Seed), Investors in Enterprise Infrastructure (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Infrastructure (Series A), Investors in Enterprise Infrastructure (Seed), Investors in Health IT (Seed), Investors in Consumer Internet (Series A), Investors in Enterprise (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Enterprise (Seed)
to see your intro paths to Lynn
Photo of Tasneem Dohadwala, Managing Director at Golden Seeds Fund LP
Tasneem Dohadwala
Golden Seeds Fund LP·Managing Director
Sweet spot: $1M
Range: $250K - $2.0M
Investors in New York (NY)
Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Internet (Seed), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Infrastructure (Seed), Investors in Enterprise Infrastructure (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Infrastructure (Series A), Investors in Enterprise Infrastructure (Seed), Investors in Health IT (Seed), Investors in Consumer Internet (Series A), Investors in Enterprise (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Enterprise (Seed)
to see your intro paths to Tasneem